Research interests include Autophagy in Disease and Therapy, Cellular transport and secretion, Chronic Lymphocytic Leukemia Research, and Chronic Myeloid Leukemia Treatments.
[To compare the efficacy and incidence of severe hematological adverse events of flumatinib and imatinib in patients newly diagnosed with chronic phase chronic myeloid leukemia].